Re­cent use of Pfiz­er's Covid pill de­clines sharply com­pared to this sum­mer

Pfiz­er’s block­buster Covid-19 an­tivi­ral Paxlovid has helped many Amer­i­cans avoid the hos­pi­tal since it was au­tho­rized late last year, but the num­ber of those us­ing the an­tivi­ral has fall­en by al­most half since mid-sum­mer.

Be­tween June 19 and Aug. 21 (63 days), the US ad­min­is­tered 2.5 mil­lion cours­es of Paxlovid, but over the next, near­ly two months ― Aug. 21 to Oct. 16 (56 days) — just 1.2 mil­lion cours­es were ad­min­is­tered, ac­cord­ing to da­ta from the fed­er­al gov­ern­ment’s Ad­min­is­tra­tion for Strate­gic Pre­pared­ness and Re­sponse.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER